Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy.

EBioMedicine · 2021 · PMC8417304 · PMID 34482070

Europe PMC DOI

hedged sentence

0.0860

closest p · 1.7× alpha

0.0860

boldest claim

The sentences

marginally significantP =0.086so close (0.05 < p ≤ 0.1)

There was a marginally significant advantage of DFS in ACSL4 high-expression group over the low-expression group (log-rank P =0.086), while ACSL4 expression could serve as an independent prognostic factor of DFS in the multivariate analysis (adjusted HR=0.283, 95% CI 0.083–0.966, P =0.044; likelihood ratio test; Fig. 8 a).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.